Dongsheng Duan's interest in gene therapy to treat diseases goes back a long way, although his initial focus wasn't muscular dystrophy.
"I came to the muscle field by accident," says Duan, an MDA research grantee and professor of molecular microbiology and immunology at the University of Missouri at Columbia. "It was not something I intended to do when I was young."
Update (June 16, 2014): As of June 2014, the following seven centers comprise the MDA DMD Clinical Research Network: University of California, Davis; Nemours Children's Hospital, Orlando, Fla.; Boston Children's Hospital; University of Minnesota Medical Center, Minneapolis; Washington University, St. Louis; Nationwide Children's Hospital, Columbus, Ohio; and Children's Medical Center of...
Featured in this issue: First U.S. exon-skipping trial opens * Utah researchers seek families with Ullrich CMD or Bethlem myopathy * Acceleron receives Fast Track, Orphan Drug designations for ACE031 * BioMarin abandons BMN195 development
Emanuela Gussoni, Ph.D.
AffiliationChildren’s Hospital and Harvard University, Boston
StrategyIsolating side population cells from muscle tissue